Lightnews — Scholar-powered news

Reposted by Oncology Nurse, MSN, RN

@lcrf.org

Thank you to Merck for signing on as a National Sponsor for the Free to Breathe Walk!

LCRF.org/Walk

#LungCancerAwareness
#FreetoBreatheWalk

September 28, 2025 at 9:20 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

UNGA 80: Highlights from the Fourth High-Level Meeting on NCDs and Mental Health

@drtedros.who.int
@uiccofficial.bsky.social

oncodaily.com/voices/unga-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #UNGA80

UNGA 80: Highlights from the Fourth High-Level Meeting on NCDs and Mental Health - OncoDaily

UNGA 80: Highlights from the Fourth High-Level Meeting on NCDs and Mental Health / Alejandra Mendez, cancer, Elin Jäger, Georgie Kovacs, Gianluca Pettiti,

oncodaily.com

September 28, 2025 at 10:47 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

Join us for the DC Lung Cancer Conference on October 4th - Stephen V Liu

@stephenvliu.bsky.social

oncodaily.com/voices/steph...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DCLung25 #LungCancer

Stephen V Liu: Join us for the DC Lung Cancer Conference on October 4th - OncoDaily

Stephen V Liu: Join us for the DC Lung Cancer Conference on October 4th / cancer, DC Lung Cancer Conference, DCLung25, Lung cancer, OncoDaily, Oncology,

oncodaily.com

September 15, 2025 at 1:01 PM

Reposted by Oncology Nurse, MSN, RN

ONCOassist® | The go-to oncology app

@oncoassist.bsky.social

🚨BREAKING: Novocure’s Optune Lua® approved in for unresectable advanced/recurrent #NSCLC.
✅ Can be used with PD-1/PD-L1 inhibitors after platinum chemo
📊 Backed by Phase 3 LUNAR trial, showing significant OS benefit

🔗 Read more: bit.ly/ONCOnews16S-1

September 16, 2025 at 10:30 AM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

Radiotherapy for Pancreatic Cancer: Types, Success Rate, Side Effects And More

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Radiotherapy #PancreaticCancer

Radiotherapy for Pancreatic Cancer: Types, Success Rate, Side Effects And More - OncoDaily

Radiotherapy for Pancreatic Cancer: Types, Success Rate, Side Effects And More / cancer, OncoDaily, OncoDaily GI, Oncology, Pancreatic Cancer, radiation

oncodaily.com

September 14, 2025 at 1:19 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

Finding Better Treatments for Patients with Non-clear Cell Renal Cell Carcinoma - Tian Zhang

@tiansterzhangmd.bsky.social

oncodaily.com/voices/tian-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RCC #RenalCellCarcinoma

Tian Zhang: Finding Better Treatments for Patients with Non-clear Cell Renal Cell Carcinoma - OncoDaily

Tian Zhang: Finding Better Treatments for Patients with Non-clear Cell Renal Cell Carcinoma / cancer, kidney cancers, Lisa Henske, OncoDaily, Oncology, Tian

oncodaily.com

September 14, 2025 at 1:22 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

10 Must-Read Posts in Immuno-Oncology This Week

@patrickhwumd.bsky.social

oncodaily.com/societies/im...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IO #ImmunoOncology

10 Must-Read Posts in Immuno-Oncology This Week - OncoDaily

This week’s expert highlights in immuno-oncology spotlight trial updates, novel combinations, and leading voices shaping the future of cancer immunotherapy.

oncodaily.com

September 14, 2025 at 1:25 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

INLEXZO FDA Approval: A Game-Changer in Bladder Cancer Treatment

oncodaily.com/fda-approval...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #INLEXZO #FDAApproval #BladderCancer

INLEXZO FDA Approval: A Game-Changer in Bladder Cancer Treatment - OncoDaily

INLEXZO FDA approval brings new hope for BCG-unresponsive bladder cancer, offering a bladder-sparing, high-response alternative to surgery.

oncodaily.com

September 14, 2025 at 1:28 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

IASLC - New Lung Cancer Considered Episode in Mandarin

@iaslc.bsky.social

oncodaily.com/voices/lung-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LungCancerConsidered #IASLC

New Lung Cancer Considered Episode in Mandarin - IASLC - OncoDaily

New Lung Cancer Considered Episode in Mandarin - IASLC / cancer, Chunxia Su, IASLC, Lung Cancer Considered, Nan Bi, OncoDaily, Oncology, The International

oncodaily.com

September 14, 2025 at 1:30 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

An Amazing Cancer Biology Department Driving Advances Across Advocate Health - Ruben Mesa

@rubenmesamd.bsky.social

oncodaily.com/blog/ruben-m...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Ruben Mesa: An Amazing Cancer Biology Department Driving Advances Across Advocate Health - OncoDaily

Ruben Mesa: An Amazing Cancer Biology Department Driving Advances Across Advocate Health / advocate health, Atrium Health, cancer, cancer biology, OncoDaily,

oncodaily.com

September 14, 2025 at 1:30 PM

Reposted by Oncology Nurse, MSN, RN

OncoDaily

@oncodaily.bsky.social

New Treatments, New Biomarkers, New Hopes for HER2+ Breast Cancer - Paolo Tarantino

@ptarantinomd.bsky.social

oncodaily.com/voices/paolo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer

Paolo Tarantino: New Treatments, New Biomarkers, New Hopes for HER2+ Breast Cancer - OncoDaily

Paolo Tarantino: New Treatments, New Biomarkers, New Hopes for HER2+ Breast Cancer / cancer, Medscape PBCC25, Mohamed Kahila, OncoDaily, Oncology, Paolo

oncodaily.com

September 14, 2025 at 1:31 PM

Reposted by Oncology Nurse, MSN, RN

Lung Cancer Research Foundation

@lcrf.org

Thank you to AstraZeneca for sponsoring the Free to Breathe Chicago Walk on Sunday, October 5th!

LCRF.org/Chicago

#LungCancerAwareness
#FreetoBreatheWalk

September 14, 2025 at 6:01 PM

Reposted by Oncology Nurse, MSN, RN

Ishwaria Subbiah MD, MS, FASCO

@ishwaria.bsky.social

1/2: 📢Now out in The Lancet #Oncology📢 Our ASCO/COSA/ECO joint statement and global call to action on #Burnout & #ClinicianWellbeing in Cancer Care from @ascocancer.bsky.social, COSA & @europeancancer.bsky.social🔹Burnout now impacts 𝟱𝟵% of US oncologists from 45% in 2013. Action is 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹.

September 14, 2025 at 6:46 PM

Reposted by Oncology Nurse, MSN, RN

International Myeloma Foundation

@imfmyeloma.bsky.social

When you're living with myeloma, the most important thing is to never give up. What inspires you while living with myeloma? Share your story below. Plus, create an easy custom graphic to share at knowmyeloma.org Then show it off on social with the #KnowMyeloma awareness tag!

September 14, 2025 at 9:59 PM

Reposted by Oncology Nurse, MSN, RN

International Myeloma Foundation

@imfmyeloma.bsky.social

It's Blood Cancer Awareness Month! Myeloma is the 2nd most common blood cancer in the world—but awareness is still low. Repost with #KNOWMyeloma to spread awareness! Learn more about the disease at knowmyeloma.org Thanks to the Binding Site for supporting #BloodCancerAwarenessMonth.

September 7, 2025 at 3:16 PM

Reposted by Oncology Nurse, MSN, RN

Lung Cancer Research Foundation

@lcrf.org

Thank you to the Rush University Medical Center for sponsoring the Free to Breathe Chicago Walk on Sunday, October 5!

LCRF.org/Chicago
#LungCancerAwareness
#FreetoBreatheWalk